Engrail Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Engrail Therapeutics's estimated annual revenue is currently $10.1M per year.
- Engrail Therapeutics's estimated revenue per employee is $245,122
- Engrail Therapeutics's total funding is $221M.
Employee Data
- Engrail Therapeutics has 41 Employees.
- Engrail Therapeutics grew their employee count by 46% last year.
Engrail Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Technical Officer | Reveal Email/Phone |
3 | VP, Corporate Development | Reveal Email/Phone |
4 | VP, BD and Commercial Strategy | Reveal Email/Phone |
5 | SVP Nonclinical Development, Head Pharmacokinetics and Drug Metabolism | Reveal Email/Phone |
6 | Director, Clinical Operations | Reveal Email/Phone |
7 | Senior Director, CMC | Reveal Email/Phone |
8 | Chief Scientific Officer | Reveal Email/Phone |
9 | Sr. Director Program Management | Reveal Email/Phone |
10 | Director, Clinical Operations | Reveal Email/Phone |
Engrail Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Engrail Therapeutics?
We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.
keywords:N/A
$221M
Total Funding
41
Number of Employees
$10.1M
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Engrail Therapeutics News
Engrail Therapeutics, a neuroscience company focused on the acquisition, development and commercialization of patient-centric therapies,...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.9M | 41 | N/A | N/A |
#2 | $4.8M | 41 | 0% | N/A |
#3 | $3.2M | 41 | 28% | $43M |
#4 | $8.2M | 41 | 11% | N/A |
#5 | $3.9M | 41 | 11% | N/A |